Aurinia Pharm Ord (AUPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,397 | 81,707 | 89,001 | 94,172 | 86,052 |
| Marketable Securities | 291,503 | 269,006 | 272,533 | 295,218 | 290,592 |
| Receivables | 37,946 | 19,499 | 19,046 | 13,483 | 41,771 |
| Inventories | 32,820 | 33,155 | 31,745 | 24,752 | 25,320 |
| Other current assets | 1,645 | 1,208 | 1,227 | 1,334 | 3,808 |
| TOTAL | $426,469 | $415,907 | $423,648 | $442,539 | $459,702 |
| Non-Current Assets | |||||
| PPE Net | 3,496 | 3,650 | 3,842 | 3,650 | 3,758 |
| Investments And Advances | 591 | 0 | 0 | 0 | 0 |
| Intangibles | 5,261 | 5,683 | 6,101 | 6,425 | 6,839 |
| Other Non-Current Assets | 119,196 | 123,660 | 18,170 | 18,246 | 17,994 |
| TOTAL | $128,544 | $132,993 | $28,113 | $28,321 | $28,591 |
| Total Assets | $555,013 | $548,900 | $451,761 | $470,860 | $488,293 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 52,309 | 41,375 | 35,965 | 39,990 | 40,123 |
| Other current liabilities | 2,611 | 2,088 | 1,979 | 2,033 | 724 |
| TOTAL | $73,890 | $61,661 | $42,046 | $46,107 | $41,765 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,662 | 3,228 | 3,157 | 3,148 | N/A |
| Other Non-Current Liabilities | 17,053 | 15,525 | 19,307 | 19,318 | 7,270 |
| TOTAL | $89,246 | $94,947 | $19,307 | $19,318 | $23,103 |
| Total Liabilities | $163,136 | $156,608 | $61,353 | $65,425 | $64,868 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 143,608 | 143,423 | 143,034 | 142,577 | 142,110 |
| Common Shares | 1,198,560 | 1,196,480 | 1,193,019 | 1,185,309 | 1,184,020 |
| Retained earnings | -915,447 | -902,000 | -890,508 | -864,302 | -838,256 |
| Other shareholders' equity | -947 | -1,020 | -988 | -1,061 | -1,527 |
| TOTAL | $391,877 | $392,292 | $390,408 | $405,435 | $423,425 |
| Total Liabilities And Equity | $555,013 | $548,900 | $451,761 | $470,860 | $488,293 |